Genetic models of apoptosis-induced proliferation decipher activation of JNK and identify a requirement of EGFR signaling for tissue regenerative responses in Drosophila by Fan, Yun et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
University of Massachusetts Medical School Faculty Publications 
2014-01-30 
Genetic models of apoptosis-induced proliferation decipher 
activation of JNK and identify a requirement of EGFR signaling for 
tissue regenerative responses in Drosophila 
Yun Fan 
University of Massachusetts Medical School Worcester 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/faculty_pubs 
 Part of the Cancer Biology Commons, Cell Biology Commons, Genetics Commons, and the Molecular 
Genetics Commons 
Repository Citation 
Fan Y, Wang S, Hernandez J, Yenigun VB, Hertlein G, Fogarty CE, Lindblad JL, Bergmann A. (2014). Genetic 
models of apoptosis-induced proliferation decipher activation of JNK and identify a requirement of EGFR 
signaling for tissue regenerative responses in Drosophila. University of Massachusetts Medical School 
Faculty Publications. https://doi.org/10.1371/journal.pgen.1004131. Retrieved from 
https://escholarship.umassmed.edu/faculty_pubs/420 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in University of 
Massachusetts Medical School Faculty Publications by an authorized administrator of eScholarship@UMMS. For 
more information, please contact Lisa.Palmer@umassmed.edu. 
Genetic Models of Apoptosis-Induced Proliferation
Decipher Activation of JNK and Identify a Requirement
of EGFR Signaling for Tissue Regenerative Responses in
Drosophila
Yun Fan1¤* , Shiuan Wang2, Jacob Hernandez3, Vildan Betul Yenigun3, Gillian Hertlein4,
Caitlin E. Fogarty1, Jillian L. Lindblad1, Andreas Bergmann1,2,3*
1University of Massachusetts Medical School, Department of Cancer Biology, Worcester, Massachusetts, United States of America, 2Graduate Program in Developmental
Biology, Baylor College of Medicine, Houston, Texas, United States of America, 3MD Anderson Cancer Center, Department of Biochemistry & Molecular Biology, Houston,
Texas, United States of America, 4 La¨nderinstitut fu¨r Bienenkunde, Humboldt Universita¨t zu Berlin, Hohen Neuendorf, Germany
Abstract
Recent work in several model organisms has revealed that apoptotic cells are able to stimulate neighboring surviving cells
to undergo additional proliferation, a phenomenon termed apoptosis-induced proliferation. This process depends critically
on apoptotic caspases such as Dronc, the Caspase-9 ortholog in Drosophila, and may have important implications for
tumorigenesis. While it is known that Dronc can induce the activity of Jun N-terminal kinase (JNK) for apoptosis-induced
proliferation, the mechanistic details of this activation are largely unknown. It is also controversial if JNK activity occurs in
dying or in surviving cells. Signaling molecules of the Wnt and BMP families have been implicated in apoptosis-induced
proliferation, but it is unclear if they are the only ones. To address these questions, we have developed an efficient assay for
screening and identification of genes that regulate or mediate apoptosis-induced proliferation. We have identified a subset
of genes acting upstream of JNK activity including Rho1. We also demonstrate that JNK activation occurs both in apoptotic
cells as well as in neighboring surviving cells. In a genetic screen, we identified signaling by the EGFR pathway as important
for apoptosis-induced proliferation acting downstream of JNK signaling. These data underscore the importance of genetic
screening and promise an improved understanding of the mechanisms of apoptosis-induced proliferation.
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Introduction
Apoptosis is the major form of programmed cell death. It is used
during development and under stress conditions to remove excess,
unwanted or damaged cells. Deregulated apoptosis can give rise to
malignancies including cancer and neurodegeneration [1]. A
central step for the execution of apoptosis is the activation of
caspases, a family of cysteine-proteases that are ubiquitously
expressed as inactive zymogens [2]. There are two different types
of caspases. Initiator caspases are activated by incorporation into
multimeric complexes such as the apoptosome [3] in response to
developmental signals, cellular stress and injury. The initiator
caspase complex cleaves and activates effector caspases which then
proteolytically process a large number of cellular proteins inducing
the death of the cell.
Caspases are very well conserved in the animal kingdom. Of the
seven caspases in Drosophila, only the initiator caspase Dronc and
the two effector caspases DrICE and Dcp-1 have been implicated
in apoptosis in imaginal discs [4–12]. Caspases are negatively
regulated by inhibitor of apoptosis proteins (IAP) which directly
bind to processed caspases and inhibit their activity [13]. Drosophila
IAP1 (Diap1) binds to and inhibits Dronc, DrICE and Dcp-1
[14,15]. In cells committed to die, IAP-antagonists such as Reaper,
Hid and Grim [16–18] promote ubiquitin-mediated degradation
of Diap1, thus releasing Dronc, DrICE and Dcp-1 from Diap1
inhibition [19–23]. Dronc associates with the scaffolding protein
Ark (Apaf-1 related killer) to form the apoptosome which triggers
activation of DrICE and Dcp-1.
Developing organisms have the ability to compensate for
massive apoptotic cell loss by inducing compensatory proliferation.
For example, developing Drosophila imaginal discs can form a
normal-sized and patterned organ even after more than 50% of
their cells have been killed by X-ray treatment due to compen-
satory proliferation [24]. Surprisingly, work in Drosophila, and later
in hydra, Xenopus, planarians, newt and mice, has revealed that
apoptotic caspases may be the driving force for compensatory
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proliferation in apoptotic tissue [12,25–35] (reviewed in [36–38]).
Because this regenerative proliferation requires apoptotic caspases,
it has been termed Apoptosis-induced Proliferation, henceforth
referred to as AiP [38,39].
There are two commonly used experimental models that study
AiP in larval imaginal discs, usually wing and eye discs in Drosophila.
The first type of model takes advantage of the fact that another
caspase inhibitor, the P35 protein from Baculovirus, specifically
inhibits the effector caspases DrICE and Dcp-1, but not the initiator
caspase Dronc [14,40,41]. Therefore, induction of apoptosis in p35-
expressing cells triggers the apoptotic pathway down to Dronc, but
cannot execute cell death because of inhibition of effector caspases by
P35. These cells are referred to as ‘undead’ cells. Consequently,
Dronc is functional in ‘undead’ tissues and can fulfill non-apoptotic
roles including AiP which triggers overgrowth [12,25–28] whichmay
be relevant for tumorigenesis. More, recently, P35-independent
models of AiP have been described [42–44]. In these models,
apoptosis is temporally induced followed by analysis of the events
leading to replacement of the dying tissue. Because they mimic the
conditions of normal regenerative growth, we referred to them as
‘genuine’ AiP models [45].
Much of what we know about AiP came from studies of
‘undead’ cells. In ‘undead’ cells, Dronc activates p53 and the
stress-kinase JNK, encoded by basket (bsk) in Drosophila [12,25–
27,46,47]. JNK activity is both necessary and sufficient to induce
AiP, and it may do this by expression of the Wnt family members
wingless (wg) and the TGFb/BMP-family member decapentaplegic
(dpp), both of which are potent mitogens [26,27,42,43,48–51].
There are similarities and differences between the ‘undead’ and
‘genuine’ models. Both models involve JNK signaling, but the
location of JNK activity appears to be different. While it is believed
that under p35-expressing conditions, JNK activity occurs only in
‘undead’ cells [27], this is less clear in the ‘genuine’AiP model.
Initially, it was reported that JNK is activated only in neighboring
surviving cells [43]. More recently, it was shown that JNK is
activated in both apoptotic and neighboring, surviving cells [44].
The role of Wg and Dpp in both models is also unclear. wg is not
induced in all ‘undead’ cells and concern has been raised about the
involvement of wg and dpp in ‘genuine’ AiP [26,44,46] suggesting
that other signaling pathways are also critical for AiP.
There are many other open questions in the field. For example,
although it is well established that Dronc can stimulate JNK
activity, the molecular mechanism of this interaction is not known.
Furthermore, while JNK is best characterized for its ability to
induce apoptosis [52], it is not always known how JNK induces
proliferation [50,53]. For example, while in wing imaginal discs,
JNK stimulates proliferation through activation of Yorkie, the
downstream target of the Hippo growth control pathway, this does
not appear to be a mechanism in eye imaginal discs [54,55], the
preferred model of this study (see below). This question is also
relevant for understanding of tumorigenesis, as for example death
receptor signaling by Fas (CD95) can promote tumor growth
through JNK-induced proliferation [56]. These considerations
stress the necessity of a convenient genetic screening system to
identify the genes and mechanisms involved in AiP.
Here, we present and test the feasibility of ‘undead’ and
‘genuine’ genetic models of AiP in eye imaginal discs. We identify
additional components in the JNK pathway that mediate the
activation of JNK by Dronc. We show that JNK activation occurs
in dying cells as well as in neighboring surviving cells depending on
the conditions used. We report the results of a pilot screen using
the ‘undead’ AiP model that led to the identification of Spi/EGFR
signaling as essential component for AiP. Finally, we demonstrate
that Spi is at least partially required for regeneration in a ‘genuine’
AiP model of the eye disc.
Results
The ey.hid-p35 model
eyeless (ey) is a regulatory gene for eye development and is
expressed during the growth phase of eye imaginal discs [57]. With
the move of the morphogenetic furrow (MF) in 3rd instar larvae, ey
expression ceases in and posterior to the MF [57]. Therefore, co-
expression of hid and p35 during the growth phase of the eye disc
using ey-Gal4 (referred to as ey.hid-p35) may provide a convenient
model to induce AiP. Correspondingly, in eye imaginal discs, the
anterior portion of the eye disc is overgrown compared to controls
forming an expanded head capsule due to increased cell proliferation
[29] (Figure 1A,B,C,D). Additional ocelli and bristles are observed
(Figure 1D, arrow). The anterior overgrowth is at the expense of
posterior tissue (Figure 1A,B) which specifies the retina. As a result,
eyes are smaller than wild-type and often absent (Figure 1E,F). In eye
discs, we use ELAV labeling which labels photoreceptor neurons, as
a marker to assess the extent of anterior overgrowth and distortion of
the eye disc (Figure 1B,G). We refer to these phenotypes as AiP
phenotypes. The small eye tissue is likely due to the expansion of Wg
expression anterior to the MF (Figure 1G,H) which is an inhibitor of
MF progression [58]. We also observed anterior expansion of dpp-
lacZ expression [29]. Finally, expression of the JNK marker puc-lacZ
and TRE-dsRed [59] are strongly expanded anterior to the MF
(Figure 1I,J; Suppl. Figure S1). Therefore, knownmarkers of AiP are
induced in the ey.hid-p35 model which therefore may represent a
convenient AiP model for genetic screening.
The ey.hid-p35 model requires the apoptosome
components dronc and ark, but is independent of
effector caspases
To test the feasibility of the ey.hid-p35 model for genetic
screening, we first examined if mutants and RNA interference
Author Summary
Work in recent years has revealed that apoptotic caspases
not only induce apoptosis, but also have non-apoptotic
functions. One of these functions is apoptosis-induced
proliferation, a relatively recently discovered phenomenon
by which apoptotic cells induce proliferation of surviving
neighboring cells. This phenomenon may have important
implications for stem cell activity, tissue regeneration and
tumorigenesis. Here, we describe the development of a
genetic model of apoptosis-induced proliferation and the
use of this model for convenient and unbiased genetic
screening to identify genes involved in the process. We
tested mutants of our RNAi transgenic lines targeting the
core components of the apoptotic pathway and of JNK
signaling, a known mediator of apoptosis-induced prolif-
eration. These assays demonstrate the feasibility of the
system for systematic genetic screening and identified
several new genes upstream of JNK that are involved in
apoptosis-induced proliferation. Finally, we tested the
model in a pilot screen for chromosome arm 2L and
identified spi, the EGF ligand in flies, as important for
apoptosis-induced proliferation. We confirmed the in-
volvement of EGF in a genuine apoptosis-induced regen-
eration system. These data underscore the importance of
genetic screening and promise an improved understand-
ing of the mechanisms of apoptosis-induced proliferation
and regeneration.
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(RNAi) of caspases and ark genetically modify the AiP phenotype.
Heterozygosity of dronc and dronc RNAi strongly suppressed the
AiP phenotype (Figure 2A,B). Under these conditions, more than
95% of the flies display completely normal eye and head
morphology. Heterozygosity of the apoptosome component ark
also suppresses the AiP phenotype to a similar extend (Figure 2C).
Therefore, these data demonstrate that the ey.hid-p35 model is
sensitive to genetic alterations and extend previous findings that
AiP not only requires dronc, but also ark, i.e. a functional
apoptosome.
Because this type of AiP is dependent on effector caspase
inhibition by P35, it was inferred that it does not require effector
caspases [25,27,28]. However, it was recently suggested that
despite P35 inhibition, effector caspases may still be active at low
levels in ‘undead’ cells [60]. This low level effector caspase
activity may be insufficient to induce apoptosis, but sufficient to
trigger non-apoptotic functions such as invasive behavior of
‘undead’ cells [60]. To test this possibility for AiP, we further
reduced DrICE and Dcp-1 activity by double RNAi due to the
redundancy of these two effector caspases [8]. However, in
contrast to the invasive behavior of ‘undead’ cells [60], the AiP
phenotype was not suppressed by dcp-1;drICE double RNAi
(Figure 2D). The RNAi stocks used are functional as dcp-1;drICE
double RNAi suppresses hid activity in a different apoptotic
model, GMR-hid (Suppl. Figure S2). In summary, the overgrowth
of the ey.hid-p35 model is dependent on the apoptosome
Figure 1. The ey.hid-p35 model induces hyperplastic overgrowth and displays markers of apoptosis-induced proliferation. In this
and the following figures, anterior is to the left. White dotted lines indicate the anterior portion of the eye imaginal discs. ELAV labels photoreceptor
neurons and is used to mark the developing eye field posterior to the morphogenetic furrow (MF). (A,A9) An ey.p35 control eye disc labeled with
PH3 as proliferation marker (red in A; grey in A9) and ELAV (green in A). (B,B9) An ey.hid-p35 experimental disc labeled with PH3 (red in B; grey in B9)
and ELAV (green in B). Please note the increase in size of the region anterior to the MF at the expense of the posterior region (green). (C,D,E,F) Dorsal
views of heads (C,D) and eyes (E,F) of ey.p35 control (C,E) and ey.hid-p35 experimental flies (D,F). Enlarged head cuticle with additional ocelli and
bristles (arrows) is observed in ey.hid-p35 flies (D), while eyes are reduced in size (F). (G,G9,H,H9) Increased expansion of wg expression (wg-lacZ, red
in G,H; grey in G9,H9) in ey.hid-p35 discs (H, arrow) compared to ey.p35 control discs (G). (I,I9) In ey.p35 control discs, puc-lacZ expression (b-Gal; red
in I, gray in I9) as marker of Bsk/JNK activity is low anterior to the MF and induced posterior to the MF. (J,J9) puc-lacZ expression (b-Gal; red in J, gray in
J9) as marker of Bsk/JNK activity is strongly induced anterior to the MF in ey.hid-p35 eye discs (arrows). Note the reduction in the posterior eye field
as visualized by ELAV labeling (green).
doi:10.1371/journal.pgen.1004131.g001
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components Dronc and Ark, but independent of effector
caspases.
Identification of JNK pathway components involved in
AiP
It is unknown how the apoptosome induces JNK activity for
AiP. To obtain further insight into this question, we tested
components of the JNK pathway in a pilot RNAi screen for
modification of the ey.hid-p35 model. As expected, RNAi
targeting bsk, the JNK ortholog in Drosophila, completely suppresses
the AiP phenotypes in more than 90% of the flies (Figure 2E,F,G).
Downstream of JNK, RNAi knockdown of the components of the
AP1 transcription factor, jun-related antigen (jra) and the Fos ortholog
kayak (kay), also suppressed the ey.hid-p35 AiP phenotypes,
although to a lesser extent (Figure 2F,G) suggesting that they are
at least partially required for AiP.
To identify upstream components in the JNK pathway involved
in AiP, we tested RNAi lines targeting all known components in
the JNK pathway [52]. Interestingly, only a subset of them were
found to suppress the AiP phenotypes (Figure 2F,G). This includes
Figure 2. Modification of the ey.hid-p35 phenotype by JNK pathway components. (A–E) dronc (A) and ark (C) heterozygosity strongly
suppresses the ey.hid-p35 phenotype (compare to Figure 1D). RNAi targeting dronc (B) and bsk (E) also strongly suppresses it. Double RNAi targeting
dcp-1 and drICE (D) has no effect. (F) Results of the suppression of ey.hid-p35 using RNAi targeting components of the Bsk/JNK pathway in
Drosophila. Only select members of the Bsk/JNK pathway (dTraf2, Rho1, dTAK1, dMKK4, Bsk and to a weaker extent hep, Jra and kay) show suppression.
Each RNAi analysis was repeated at least twice with scoring more than 50 ey.hid-p35/dsRNA adult flies. (G) Schematic summary of the suppression
analysis of the Bsk/JNK pathway. Pathway components highlighted in red show RNAi-mediated suppression and are thus required for ey.hid-p35-
induced proliferation. (H–J) The GMR.eiger-induced eye ablation phenotype (H) is strongly suppressed by dTRAF2 RNAi (I), but not by Rho1 RNAi (J).
(K) GMR-Gal4 driven RNAi targeting Rho1 does not cause an eye ablation phenotype. This control experiment shows that failure of Rho1 RNAi to
suppress GMR.eiger (J) is not due to a secondary effect.
doi:10.1371/journal.pgen.1004131.g002
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the JNKKK dTak1 and the JNKKs hemipterous (hep) and MKK4
(Figure 2F,G). The non-redundant functions of hep and MKK4 for
AiP is puzzling, but has been previously reported in different
contexts [61,62]. Further upstream in the JNK signaling pathway,
we only identified Traf2 (also known as Traf6) as AiP suppressor
(Figure 2F,G). Another regulator of JNK signaling, the small
GTPase Rho1 [63–66], was also identified as AiP suppressor. In
contrast, the two ligand/receptor systems known to activate JNK,
Eiger/Wengen and Pvf/PVR, do not suppress AiP (Figure 2F,G).
The RNAi lines against these genes are functional as shown in
Suppl. Figure S3 and in [67–69].
Theoretically, it is possible that the suppression of AiP by these
RNAi transgenes is an indirect result of suppression of apoptosis,
as observed in the case of dronc and ark mutants or RNAi
(Figure 2B,C; Suppl. Figure S4B). To exclude this possibility, we
labeled ey.hid-p35 eye imaginal discs expressing these RNAi
constructs with cleaved Caspase-3 (Cas3*) antibody, a marker of
Dronc activity [70], and ELAV antibody to evaluate rescue of disc
morphology. Despite the rescue of disc morphology, Cas3*
labeling is not significantly suppressed by these RNAi constructs
(Suppl. Figure S4C–H) suggesting that the suppression of the AiP
phenotype by reducing JNK activity is not due to suppression of
caspase activity.
Because Rho1 is the least well characterized regulatory
component in the JNK pathway, we examined the effect of Rho1
knockdown on JNK activity in the AiP model. Loss of Rho1
suppresses puc-lacZ in ey.hid-p35 eye discs (Suppl. Figure S5A,B).
Rho1 RNAi also suppresses the AiP marker Wg (Suppl. Figure
S5C,D). These data show that Rho1 acts genetically upstream of
JNK in the AiP model consistent with previous reports [63–66].
To further place Rho1 into the AiP pathway and to relate it to
Traf2, we examined the ability of Rho1 and Traf2 to suppress GMR-
eiger, a known inducer of JNK activity causing a strong eye ablation
phenotype (Figure 2H) [71,72]. Interestingly, while Traf2 knock-
down effectively suppresses GMR-eiger as reported [73], Rho1 RNAi
does not (Figure 2I,J). It is possible that Rho1 RNAi disrupts eye
development by itself and that may be the reason for the failure to
suppress GMR-eiger. However, Rho1 RNAi does not disrupt eye
development (Figure 2K). These observations suggest that the role
of Rho1 for JNK activation is independent of Eiger which is also
consistent with the observation that Eiger knockdown does not
suppress AiP (Figure 2F,G). Furthermore, these data raise the
possibility that Traf2 serves as an integration point of both Eiger
signaling and AiP for JNK activation. For these reasons, we place
Rho1 upstream of Traf2 in the AiP pathway (Figure 2G), but there
may also be other ways by which Rho1 controls JNK activation.
Activation of JNK signaling in ‘undead’/dying cells and
neighboring, surviving cells
The lack of a requirement of Eiger/Wengen and Pvf/PVR in
our AiP model (Figure 2F,G) may suggest that activation of JNK
occurs in dying cells. However, conflicting data have been
reported about the location of JNK activity in various AiP models.
Initially, JNK signaling was observed in ‘undead’ cells [27]. In a
p35-independent regeneration model, it was reported that JNK
signaling occurs only in neighboring surviving cells [43]. More
recently, JNK activity was reported to be both in dying and
neighboring surviving cells [44]. While there are experimental
differences between these studies, none of them used a mosaic
approach to determine the location of JNK activation. Therefore,
to clarify this issue, we re-examined both ‘undead’ and ‘genuine’
AiP models for location of JNK activity.
In a mosaic ‘undead’ model, we expressed hid and p35 in clones
in eye and wing discs using a FLP-out approach and analyzed puc-
lacZ expression as JNK reporter. GFP was used to mark hid/p35-
expressing clones. Using this approach, puc-lacZ is predominantly
expressed in hid/p35 expressing cells (Figure 3A,B; arrows).
However, we also noted a few examples where puc-lacZ was
expressed in GFP2 tissue (Figure 3A,B; arrowheads). These
observations suggest that JNK activation occurs largely in ‘undead’
cells, but also in neighboring, normal cells.
To address this question in a ‘genuine’ (p35-independent) AiP
model, we repeated the experiments by Bergantinos et al. (2010)
[43] in wing imaginal discs. These authors reported JNK activity
in neighboring surviving cells only. We induced hid in a temporally
and spatially controlled manner using ptc-Gal4 and tub-Gal80ts
(ptcts.hid) by temperature shifts for various times. In control
experiments, just expressing GFP in the ptc domain does not affect
the puc-lacZ pattern (Figure 3C,C90). However, when hid expression
was induced, depending on the conditions, different results were
obtained regarding the location of JNK activity. In response to a
short pulse (6 hours) of hid expression followed by a 6 hours
recovery period (ts6hR6h), an elevation of puc-lacZ activity was
detected in dying cells and neighboring, surviving cells (Figure 3E0,
E90; dying cells containing puc-lacZ are highlighted by arrows,
while surviving cells are marked by arrowheads). This JNK activity
was induced during the recovery period, because immediately
after hid induction (ts6hR0h), no alteration of puc-lacZ expression
was detected (Figure 3D90). However, when hid expression was
induced for a long period (16 hours) followed by 6 hours recovery
(ts16hRh), puc-lacZ was strongly down-regulated in dying cells,
likely as a result of apoptosis in these cells. Nevertheless,
upregulation of puc-lacZ was detected in neighboring surviving
cells (Figure 3F0, arrowheads). This result is consistent with
Bergantinos et al. (2010) [43]. However, the upregulation of puc-
lacZ still occurred in GFP+ cells (Figure 3F00,F900), i.e. in the ptc
domain which had been exposed to hid 6 hours earlier, but have
survived for unknown reasons. Similar results were observed in
Figure 3E: the surviving cells inducing puc-lacZ are located in the
GFP+ region, i.e. in the ptc domain (Figure 3E00,E900; arrowheads).
Thus, it is not clear whether JNK activity in surviving cells is
induced autonomously in response to hid expression, or by a
signaling event from the dying Cas3*-positive cells. In any case,
these data show that both in ‘undead’ and ‘genuine’ AiP models,
JNK activity can be detected in ‘undead’/dying cells as well as in
neighboring, surviving cells.
Identification of spi as AiP suppressor
A systematic mutagenesis screen for genes involved in AiP has
not been performed to date due to absence of a convenient
screening assay. However, the data presented in Figure 2
demonstrate that suppression of ey.hid-p35-induced AiP provides
a convenient assay for genetic screening. Therefore, as proof of
principle, we screened a total of 106 chromosomal deficiencies
deleting segments on the left arm of chromosome 2 (2L) for
modification of the AiP phenotype and identified four chromo-
somal segments as dominant AiP suppressors and seven deficien-
cies as dominant AiP enhancers (Table 1; Suppl. Table S1),
validating the deficiency approach. Enhancers display an even
stronger AiP phenotype with severely overgrown head cuticle and
strong semi-lethality.
To identify the genes in the deficiencies that dominantly cause
the suppression of AiP, we tested available mutants and UAS-
RNAi stocks against all genes that map to these deficiencies. This
approach has been completed for Df(2L)ED1303 (Table 1) and led
to the identification of spitz (spi) as a potential regulator of AiP
(compare Figure 4C–F,I with Figure 4A,B). spi encodes the EGF
ortholog in Drosophila [74]. Therefore, our deficiency screen raises
Genetic Models of Apoptosis-Induced Proliferation
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Figure 3. Location of Bsk/JNK signaling in ‘undead’ and ‘genuine’ AiP models. puc-lacZ was used as JNK activity marker. hid expressing
areas are marked by GFP. Arrows indicate JNK activity in ‘undead’/dying cells, while arrowheads mark JNK activity in surviving cells. A double arrow in
(C–F) marks the ptc domain. (A,B) Location of JNK signaling in ‘undead’ AiP models by mosaic analysis. Clones expressing hid and p35 were induced
by FLP-out technology. In eye (A) and wing (B) imaginal discs, puc-lacZ expression is mostly induced in hid/p35-expressing clones (arrows in A9, A0,A90,
B9, B0,B90). However, a few examples of puc-lacZ expression are noted in cells outside of hid/p35-expressing clones (arrowheads). (C–F) Location of JNK
activity in a ‘genuine’ AiP model in wing imaginal discs. hid expression was under control of ptc-Gal4 and tub-Gal80ts (ptcts.hid). A temperature shift
(ts) to 30uC for the indicated amount of time during 3rd larval instar induced hid expression. After the indicated recovery period (R), discs were labeled
for GFP (to visualize the ptc domain), Cas3* (the death domain) and b-Gal (puc-lacZ, i.e. JNK activation). The ptc domain is outlined by white, dotted
lines. Note that the death domain does not completely overlap with the ptc domain (see for example E9,E900 and F9,F900). (C–C900) A control disc just
expressing GFP under the experimental conditions to visualize the normal puc-lacZ pattern (b-Gal) pattern. (D–D900) An experimental disc that was
dissected immediately after a 6 hours pulse of hid expression without recovery (ts6hR0h). While caspase activity has been induced (D9), the puc-lacZ
pattern is mostly unaffected (D90). (E–E900) An experimental disc that was allowed to recover for 6 hours after a 6 hours pulse of hid expression
(ts6hR6h). puc-lacZ (b-Gal) expression is induced in many cells both inside (arrows) and outside (arrowheads) of the death domain (E0,E90). However,
these cells are present in the ptc domain (GFP; E00,E900). (F–F900) An experimental disc that was allowed to recover for 6 hours after a pulse of hid
expression for 16 hours (ts16hR6h). Although apoptosis is now strongly induced (F9), it is not detectable in the entire ptc domain (GFP; F900)
suggesting that some cells can escape hid-induced cell death. puc-lacZ (b-Gal) is strongly reduced in dying cells (F90). Nevertheless, there is an
increase of puc-lacZ expression in cells outside of the death domain (F0; arrowheads). However, these cells reside in the ptc expression domain
(F00,F900). Genotypes: (A,B) hs-FLP/UAS-hid; UAS-p35/act.y+.Gal4 UAS-GFP; puc-lacZ/+. (C) ptc-Gal4 tub-Gal80ts/+; UAS-GFP/puc-lacZ. (D–F) UAS-hid/+ ;
ptc-Gal4 tub-Gal80ts/+; UAS-GFP/puc-lacZ.
doi:10.1371/journal.pgen.1004131.g003
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the hypothesis that the EGFR pathway regulates AiP. Consistent-
ly, heterozygosity of Egfr suppresses the ey.hid-p35 phenotype in
eye discs (compare Figure 4G–I with Figure 4A,B). We also found
that Egfr RNAi suppresses an AiP model in wing imaginal discs
(nub.hid-p35) (Suppl. Figure S6). Downstream of EGFR, mutant
alleles of the Drosophila orthologs of Ras (Dras) and MAPK (rolled
(rl)) act as dominant suppressors of ey.hid-p35 (Figure 4I)
suggesting that MAPK activity is required for AiP. These data
imply that EGFR/Ras/MAPK signaling is essential for AiP in
both eye and wing discs. These findings are exciting giving the
controversy of the role of Wg and Dpp for AiP (see Introduction)
[26,46].
To further characterize the involvement of Spi/EGFR signaling
for AiP, we took advantage of the spi01068 allele which is an
enhancer trap insertion of lacZ into the spi gene (spi-lacZ) and can
serve as a reporter for spi expression [75]. This analysis is
complicated by the fact that this spi allele itself is a dominant
suppressor of AiP: about 75% of the ey.hid-p35/spi01068 flies show
a weak AiP phenotype, while 25% are not suppressed and still
show a moderately strong AiP phenotype (Figure 4E,F,I). Consis-
tently, in about 25% of ey.hid-p35 eye discs (n = 28), we observed
a strong induction of b-Gal labeling compared to control discs
(Figure 5A,B). This percentage corresponds to the number of
heterozygous spi01068 flies which display a moderately strong AiP
phenotype (Figure 4I). The remaining 75% of ey.hid-p35 eye discs
heterozygous for spi01068 show a normalization of disc morphology
as visualized by ELAV labeling and spi-lacZ expression (Figure 5C).
In addition, we found that a target gene of the EGFR pathway,
kekkon-1(kek) [76] is induced during AiP (Figure 5D,E,F).
To determine the position of Spi/EGFR signaling in the AiP
pathway, we performed epistasis experiments between spi and bsk.
Heterozygosity of spi1 dominantly suppresses the adult AiP
phenotype of ey.hid-p35 (Figure 4C,D,I). This suppression can also
be visualized by the normalization of the ELAV pattern in ey.hid-
p35 eye imaginal discs (Figure 5G, compare to Figure 1J). However,
despite the normalization of the ELAV pattern, puc-lacZ expression
is not reduced in this genetic background (Figure 5G,G9) suggesting
that spi acts genetically downstream of bsk. This is further confirmed
by the reciprocal experiment in which bsk RNAi completely
normalizes the spi-lacZ pattern in ey.hid-p35 background
(Figure 5H). bsk RNAi also normalizes the kek-lacZ pattern in ey.
hid-p35 background (Figure 5I). These observations suggest that
Spi/EGFR signaling acts genetically downstream of bsk activity.
Because Spi is a secreted signaling molecule, these findings may
imply that EGFR activation occurs in cells adjacent to apoptotic,
JNK-activating cells. This assumption is directly confirmed by the
observation that kek-lacZ activity, a downstream marker of EGFR
signaling, and Cas3* labeling as apoptotic marker do not overlap
(Figure 5F, arrows). In summary, these data imply that spi
expression occurs downstream of Bsk/JNK activity and that EGFR
signaling acts in signal-receiving, proliferating cells.
Characterization of ‘genuine’ AiP in the eye imaginal disc:
the DEts.hid model
Finally, we tested if genes identified in the ‘undead’ (P35-
dependent) AiP model are also involved in ‘genuine’ (P35-
independent) regeneration in the eye disc. To accomplish this
we used a similar approach as previously described in wing discs
[42–44]. hid expression was spatially restricted to the dorsal half of
the eye disc by dorsal eye-Gal4 (DE-Gal4) [77] and controlled by
Gal80ts [78] by a transient temperature shift (ts) to 30uC for
12 hours (Figure 6E). We refer to this system as DEts.hid. This
model also induces GFP to label hid-expressing cells. Before and
after the temperature shift, animals were incubated at 18uC
(Figure 6E) to inhibit Gal4 activity and therefore hid and GFP
expression. Note that although GFP is expressed only during the
30uC pulse, it is a rather stable protein and can be detected in
control discs 72 h later (Figure 6D).
In experimental discs immediately after the 30uC pulse
(recovery 0 hours – R0 h), a strong apoptotic response is
detectable (Figure 6A9) which causes tissue loss and disruption of
the bilateral symmetry of the disc 24 hours later (R24 h). In
extreme cases, this treatment can result in ablation of the entire
dorsal half (Figure 6B, asterisk), but usually some dorsal tissue
remains. At that time, many cells are still Cas3*-positive
(Figure 6B). 72 hours after the temperature shift (R72 h), the disc
has fully recovered in shape and also has a normal photoreceptor
pattern as judged by ELAV labeling (Figure 6C). Cas3* activity is
no longer detectable. The recovery is the result of increased
proliferation in the dorsal half of the eye disc (compare Figure 6G0
to Figure 6F0; quantified in Figure 6H). The reduction of the GFP
signal in the dorsal part (Figure 6C,G9) compared to the control
disc (Figure 6D) suggests that most of the GFP+ cells have died and
have been replaced by new, GFP2, cells.
Interestingly, a group of apoptotic cells appears to migrate out of the
dorsal half into the center of the disc (Figure 6B; arrow). At R72 h,
only these cells still show strongGFP+-labeling (Figure 6C; arrow). This
‘escape’ response of these ‘genuine’ apoptotic cells is reminiscent of the
invasive behavior of ‘undead’ cells in wing discs which move out of the
Table 1. Deficiencies that modify the ey.hid-p35-induced AiP phenotype as suppressors or enhancers.
Suppressors of ey.hid-p35- induced Overgrowth Chromosomal Location
Enhancers of
ey.hid-p35-induced Overgrowth Chromosomal Location
Df(2L)C144, Df(2L)ED136 22F4-23A2 Df(2L)ED123 22D1-22D3
Df(2L)ED206, Df(2L)JS17 23C4-23C5 Df(2L)BSC6 26D3-26E1
Df(2L)Exel7014, Df(2L)BSC28 23C4-23C5 Df(2L)BSC6 26D3-26E1
Df(2L)BSC31 23E5-23F3 Df(2L)ED508 28C1-28C4
Df(2L)TW137 ? Df(2L)ED611 29B4-29C3
Df(2L)ED1303, Df(2L)ED1272 37F2-38A2 Df(2L)Exel7048 31E3-31F4
Df(2L)ED1050 35C1-35D1
Df(2L)Exel7080 38F5-39A2
The indicated chromosomal location is the smallest overlap of overlapping deficiencies. Df(2L)TW137 is marked with a ‘‘?’’ because other overlapping deficiencies do not
suppress AiP (see Suppl. Table S1) indicating that the Df(2L)TW137 chromosome carries a suppressor mutation independent of the deficiency.
doi:10.1371/journal.pgen.1004131.t001
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‘undead’ domain [60]. What makes these cells move is unknown, but
an interesting avenue for further research in the future.
Requirement of bsk and spi for regeneration in the
‘genuine’ AiP model DEts.hid
Because JNK activity is essential for ‘undead’ AiP (Figure 2E),
we examined a requirement of bsk in the ‘genuine’ (P35-
independent) DEts.hid model. First, we examined if JNK activity
is induced in the DEts.hid model. Consistent with the ‘genuine’
AiP models in the wing [42–44], this was indeed observed.
TRE-dsRed as marker of JNK activity [59] peaked at 6 h after
recovery (R6 h) and is still detectable at R12 h (Suppl. Figure
S7B,C). It is mostly gone after 24 h recovery (Suppl. Figure S7D).
TRE-dsRed is confined to the GFP+ area, i.e. in the death domain
(Suppl. Figure S7B,C).
Second, we determined if bsk is genetically required for tissue
regeneration in the DEts.hid model. We used the photoreceptor
pattern (ELAV) as a marker to reveal disc outline and thus assess
the degree of regeneration. Control discs (DEts.hid) at R72 h had
completely regenerated (Figure 7A; n= 30). However, if bsk was
inactivated by RNAi during the apoptosis-inducing phase
(Figure 6E), about 35% (9 of 25 discs) of the discs show incomplete
regeneration (Figure 7B). The incomplete regeneration after bsk
RNAi is weak, presumably because the 12 h down-regulation of
bsk during the temperature shift is not sufficient to completely
remove Bsk activity. It is also possible that Bsk is resynthesized
quickly during the recovery period. Nevertheless, the incomplete
regeneration after bsk RNAi suggests that Bsk is at least partially
required for tissue regeneration after DEts.hid-induced tissue loss.
Next, we examined whether Spi/EGFR signaling is activated in
the DEts.hid model. spi-lacZ expression is induced in the ablated
GFP-expressing dorsal domain of the disc compared to controls
(Figure 7F,F9,G,G9). kek-lacZ as EGFR signaling marker is also
strongly induced in the dorsal domain compared to controls
(Figure 7H,H9,I,I9; arrow).
To determine if spi is genetically required in the DEts.hid
regeneration assay, we inactivated it by RNAi during the 30uC
temperature shift, following the protocol in Figure 6E. In a control
experiment, because spi is required for photoreceptor differenti-
ation posterior to the morphogenetic furrow [79,80], we tested if a
12 h spi RNAi treatment followed by 72 h recovery (R72 h) affects
normal photoreceptor differentiation. However, eye discs treated
in this way have a normal ELAV pattern (Figure 7C,C9; n = 20).
After this control experiment, we tested for a genetic requirement
of spi for regeneration of lost tissue due to hid expression.
Strikingly, the regeneration response as judged by ELAV labeling
was partially impaired when spi was inactivated by RNAi during
hid induction (Figure 7D,D9; arrow). All experimental discs (n = 30)
showed incomplete regeneration. The regeneration is only weakly
affected, likely because spi is inactivated by RNAi only during the
30uC pulse during hid expression (Figure 6E) and is likely restored
soon after reducing the temperature to 18uC. Nevertheless, in a
heterozygous spi condition, the discs also incompletely regenerated
after DEts.hid treatment (Figure 7E,E9; N=20). In summary,
because spi RNAi and spi heterozygosity cause a partial failure to
regenerate, these data imply a requirement of spi for regeneration
in the ‘genuine’ DEts.hid AiP model. Furthermore, these data
support the notion that genetic screening using the simpler
‘undead’ AiP model can lead to identification of genes that may
also have important roles for regeneration in ‘genuine’ AiP.
Discussion
Apoptosis-induced proliferation (AiP) appears to be a mecha-
nism by which developing organisms replace dying cells under
stress conditions and initiate regenerative responses (reviewed by
[37,45]). In this paper, we described two AiP models in the
developing Drosophila eye. The ‘undead’ ey.hid-p35 model
generates a hyperplastic overgrowth phenotype. To date this is
the only known phenotype that provides a robust and convenient
assay for genetic screening and identification of novel regulators of
Figure 4. Suppression of ey.hid-p35 by spi and Egfr inactiva-
tion. The hyperplastic phenotype of ey.hid-p35 flies can be grouped in
three categories, severe, moderate and weak. Flies were scored as
severe when the head cuticle was strongly overgrown without
discernible patterning and eyes were absent or strongly reduced in
size. A moderate phenotype was scored when the head cuticle was
overgrown, but recognizably patterned with duplicated ocelli and
bristles. A weak phenotype was scored when size of head cuticle and
eyes was almost normal with very few ectopic ocelli or bristles
occasionally observed. (A–H) Representative pictures of ey.hid-p35 fly
head cuticles scored in different categories. Completely suppressed ey.
hid-p35 phenotype (wild-type-like head cuticles) by spi or Egfr
heterozygotes are not shown here. Arrows indicate ectopic ocelli or
bristles. (A,B) About 50% of ey.hid-p35 flies show severe hyperplastic
overgrowth of the head cuticle (A), while the remaining 50% display a
moderate phenotype (B). (C–H) Heterozygosity of spi1, spi01068 and Egfrf2
almost completely eliminated the severe overgrowth phenotype of ey.
hid-p35 flies and largely extends the population of flies with a weak
phenotype. (I) Summary of the suppression of the ey.hid-p35
overgrowth phenotype in spi, egfr, dRas and rolled (rl) heterozygous
condition. Pink indicates severe, orange indicates moderate and green
indicates weak phenotypes. Mutant alleles are indicated.
doi:10.1371/journal.pgen.1004131.g004
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Figure 5. Epistasis analysis of spi and bsk. Arrowheads indicate the morphogenetic furrow (MF) which separates the anterior (left) from the
posterior eye tissue visualized by ELAV labeling. (A) spi-lacZ pattern (b-Gal; red in A; gray in A9) in ey.p35 control discs. Note there is little expression
anterior to the MF. (B,C) Because the spi-lacZ allele (spi01068) is a suppressor of ey.hid-p35 adult overgrowth phenotype (Figure 4I), there is variation
in the b-Gal pattern. About 25% of the eye discs show strong induction of spi-lacZ in the anterior portion of the eye disc (B,B9; arrows) with a strong
reduction of the eye field (ELAV). The remaining 75% of the eye discs show a suppressed, largely normal b-Gal and ELAV pattern in ey.hid-p35 larvae
(C,C9). This ratio corresponds to the suppression of the adult overgrowth phenotype (Figure 4I). (D,E) Strong induction of kek-lacZ (b-Gal; red in D,E;
gray in D9,E9) in ey.hid-p35 eye discs (E; arrows) compared to ey.p35 control discs (D). (F,F9) kek-lacZ (b-Gal; red in F, gray in F9) is preferentially
induced in patches of tissue adjacent to areas with high levels of active caspases (arrows, Cas3* in green). (G,G9) Heterozygosity of spi normalizes the
eye field (ELAV, green), but does not suppress ectopic puc-lacZ expression (b-Gal; red in G, gray in G9) in ey.hid-p35 eye discs (arrows, compare to
Figure 1J). Dotted white lines outline the region anterior to the MF. (H,H9) Expression of bskRNAi in ey.hid-p35 discs normalizes the eye field (ELAV,
green) and suppresses ectopic increase of spi-lacZ expression (b-Gal; red in H, gray in H9). This pattern was observed in all experimental discs (n = 30).
(I,I9) Expression of bskRNAi in ey.hid-p35 discs normalizes the eye field (ELAV, green) and suppresses ectopic kek-lacZ expression (b-Gal; red in I, gray in
I9; compare to E). The analysis in G, H and I strongly suggests that spi acts genetically downstream of bsk.
doi:10.1371/journal.pgen.1004131.g005
Figure 6. Characterization of ‘genuine’ AiP in the eye imaginal disc: the DEts.hid model. hid expression was under control of dorsal eye-
(DE-)Gal4 and tub-Gal80ts (DEts.hid). A temperature shift (ts) to 30uC for 12 h during 2nd larval stage induced hid expression (E). After the indicated
recovery period (R), discs were labeled for GFP (to visualize the DE expression domain), Cas3* (the death domain) and ELAV (to outline the shape of
the disc). (A–C) DEts.hid experimental discs. hid expression induces a strong apoptotic response (A) causing strong tissue loss after 24 h recovery in
some discs (panel B; R24 h, asterisk). After 72 h recovery (R72 h), the disc has fully recovered and has a normal photoreceptor pattern as judged by
ELAV labeling (C). Please note the strong reduction of GFP intensity which suggests that most of the GFP+ cells have been replaced by new GFP2
cells. Arrows highlight a patch of cells that are moving to the center of the disc. (D) A control disc 72 h after DEts-induced GFP expression. Please note
that GFP is a very stable protein that can still be detected 72 h after synthesis. (E) The protocol of the DEts.hid-induced tissue ablation followed by
recovery periods. (F,F9,F0,G,G9,G0) PH3-labeling of control (DEts.GFP; F,F0) and experimental discs (DEts.hid; G,G0). GFP marks the outline of the DE
domain (F9,G9). (H) Quantification of the number of PH3-positive cells in dorsal and ventral compartments of control (F) and experimental discs (G).
n = 40 for each genotype.
doi:10.1371/journal.pgen.1004131.g006
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AiP. In contrast, we have not identified a similar robust and
convenient phenotype that would allow direct screening for genes
involved in ‘genuine’ (p35-independent) AiP and regeneration.
Nevertheless, we developed the DEts.hid model to verify genes
identified in the ‘undead’ screen as being involved in ‘genuine’ AiP
and regeneration.
Although the use of p35 to keep dying cells in an ‘undead’
condition may be considered as unphysiological and artificial, to
date all genes identified under p35-expressing conditions such as
JNK, Wg and Spi, were also found to be involved in AiP in p35-
independent models [42,43] (this study). Furthermore, cancer cells
may resemble ‘undead’ cells. They often initiate, but cannot execute
the apoptotic program due to genetic loss or inactivation of effector
caspases or other apoptotic components [81–84]. Such ‘undead’
cancer cells may contribute to tumor growth. Therefore, our p35-
expressing AiP model could provide insights into new regulators of
AiP as well as how impaired apoptosis may promote tumor growth.
Apoptotic caspases play a critical role for AiP. In Drosophila, the
initiator caspase Dronc is required for activation of JNK activity
which triggers AiP. However, it is unknown how Dronc activates
JNK for AiP. Using RNAi, a specific subset of components in the
JNK pathway were identified as required for AiP. The most
upstream genes in the JNK pathway are Rho1 and Traf2. Traf2
appears to be an integration point for Eiger- and AiP-induced JNK
activation, the latter one being mediated through Rho1 (Figure 2G).
However, it is unknown how Dronc triggers Rho1 activation. It is
unlikely that Dronc proteolytically cleaves Rho1 for two reasons.
First, Rho1 does not contain a putative Dronc cleavage site [40,85].
Second, a proteolytic cleavage is likely to destroy Rho1; however,
our genetic analysis implies that Rho1 function is required for AiP
(Figure 2, Suppl. Figure S5). Therefore, it remains unknown how
Dronc triggers Rho1 and thus JNK activation.
Interestingly, extracellular signaling pathways (Eiger/Wengen
and Pvf/PVR) known to activate JNK [52] did not score as
Figure 7. Requirement of bsk and spi for complete regeneration in the ‘genuine’ AiP model DEts.hid. (A, A9) DEts.hid discs treated
following the protocol in Figure 6E fully recover after 72 h (R72H). n = 30. (A9) shows the ELAV-only channel. (B, B9) About 35% of DEts.hid discs
expressing UAS-bsk RNAi do not completely recover after 72 h. n = 25. The arrow in (B9) highlights the incomplete ELAV pattern on the dorsal half of
the disc indicating that the regeneration response was partially impaired by reduction of bsk activity. Please note that this disc has also been labeled
for GFP. (C, C9) A control eye disc expressing UAS-spi RNAi under DEts-control following the protocol in Figure 6E. After 72 h recovery, the obtained
ELAV pattern in the dorsal half of the eye disc is largely normal (red in C, gray in C9). n = 20. (D, D9) An experimental DEts.hid eye disc that was
simultaneously treated with spi RNAi. The arrow in (D9) highlights the incomplete ELAV pattern on the dorsal half of the disc indicating that the
regeneration response was partially impaired by reduction of spi activity. 30 out of 30 discs show incomplete regeneration. Please note that this disc
has also been labeled for GFP. (E, E9) An experimental DEts.hid eye disc that was heterozygous for spi01068. Similar to (D), the ELAV pattern is
incomplete on the dorsal half of the disc (E9, arrow). n = 20. (F, F9, G, G9) spi-lacZ pattern in control (DEts.GFP; red in F, grey in F9) and experimental
discs (DEts.hid; red in G, grey in G9) at 24 h after recovery. The arrow in (G9) points to the increased b-Gal pattern in the dorsal half of the disc. Blue is
Cas3*. (H, H9, I, I9) kek-lacZ pattern in control (DEts.GFP; red in H, grey in H9) and experimental discs (DEts.hid; red in I, grey in I9) at 30 h recovery. The
arrow in (I9) points to the increased b-Gal pattern in the dorsal half of the disc. Blue is Cas3*.
doi:10.1371/journal.pgen.1004131.g007
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suppressors of AiP, suggesting that Dronc may autonomously
activate JNK activity. This is also consistent with our observation
that JNK activity occurs largely in hid- and p35-expressing clones
(Figure 3). Nevertheless, it is also possible that a third extracellular
signal is generated by ‘undead’ cells in a Dronc-dependent manner
that triggers JNK activity in an autocrine and/or paracrine
manner. The observation that in both ‘undead’ and ‘genuine’ AiP
models JNK activity is also detectable in neighboring surviving
cells (Figure 3) may support such a mechanism. Further work is
necessary to reveal the exact mode of JNK activation by ‘undead’/
dying cells.
In the ‘genuine’ (p35-independent) AiP model (ptcts.hid), JNK
activity is detectable in both dying and surviving cells. However,
the surviving cells with increased JNK activity are also present in
the ptc domain (Figure 3E,F) which was exposed to hid expression
during the temperature shift. JNK activity is also restricted to the
death domain in the DEts.hid model (Suppl. Figure S7).
Therefore, it is unclear whether a signaling mechanism from
dying cells induces JNK activity in surviving cells, or whether the
previous hid induction accounts for the JNK activity in surviving
cells. It is also unclear how these cells survive. Even after a 16 h
pulse of hid induction causing a strong apoptotic response in a
large fraction of cells in the ptc domain, some cells survive
(Figure 3F). They may receive survival signals from cells outside of
the ptc domain, but that needs to be determined. These are
interesting questions to be addressed in the future.
We have tested signaling pathways known to be involved in
growth control for modification of the ey.hid-p35 model. One
example is the Hippo/Warts/Yorkie pathway [86,87]. However,
neither mutants of this pathway nor transcriptional reporters (ex-
lacZ) scored positive in the ey.hid-p35 model (data not shown).
Therefore, at least in the eye disc, not every pathway involved in
growth control is also involved in AiP. These observations stressed
the necessity to perform unbiased genetic screens aimed at
identifying the genes and mechanisms involved in AiP.
Therefore, we performed a pilot screen for modifiers of the ey.
hid-p35 AiP model using deficiencies of chromosome arm 2L. We
identified four deficiencies as suppressors and three as enhancers
(Table 1). Identification of AiP enhancers implies that there is also
negative regulation of AiP. In one case we identified spi, encoding
the Drosophila EGF ortholog, as a suppressor of AiP suggesting an
involvement of EGFR signaling for AiP. This is further confirmed
by the strong transcriptional induction of spi and an EGFR target
gene, kekkon, in our AiP model. We also found that EGFR signaling
is involved in an ‘undead’ AiP model in the wing and – more
importantly – in the ‘genuine’ DEts.hid regeneration model in the
eye. The latter finding is crucial as it demonstrates that genes
identified in the ‘undead’ screen may be relevant players for
‘genuine’ regeneration in response to apoptotic tissue loss. An
involvement of EGFR and MAPK for regeneration is not
unprecedented. It was previously shown that EGF is one of a
few signals that stimulate hepatocyte proliferation during liver
regeneration in mammals [88,89]. In the Hydra regeneration
model, apoptosis-induced proliferation depends on MAPK acti-
vation [90]. Therefore, these findings and considerations validate
our screening approach using the ‘undead’ AiP model.
Identification of Spi/EGFR signaling as suppressor of AiP was
unexpected because EGFR signaling negatively regulates the
apoptotic activity of hid [91,92]. Thus, by reducing EGFR activity,
hid has increased apoptotic activity which is expected to induce
even more AiP. Therefore, the AiP phenotype should be enhanced
by heterozygosity of EGFR pathway components. However, the
identification of spi, Egfr, Dras and rl as suppressor of AiP suggests
that EGFR signaling is also required for AiP. One possibility to
explain these two opposing functions of EGFR (negative
regulation of hid and positive requirement for AiP) may be the
exclusive appearance of Cas3*-positive areas and areas with
EGFR activity (Figure 5F). Accordingly, while the Spi signal is
generated in Cas3*-positive, apoptotic areas, it signals to
neighboring Cas3*-negative, surviving areas to inactivate Hid
and promote proliferation.
The identification of Spi/EGFR signaling may help to resolve a
controversy about the signaling pathways involved in AiP. The
exact roles of Wg and Dpp for AiP are unclear [26,44,46] and
signaling by the EGFR pathway may contribute to the prolifer-
ative response in AiP.
Recently, a genetic screen has been reported aimed at
identification and characterization of genes required for compen-
satory growth [93]. These authors induced apoptosis conditionally
using a temperature-sensitive cell lethal mutant (sec5ts). Under
normal conditions, the ablated tissue is replaced by new tissue due
to compensatory proliferation. The authors then screened for
mutants that fail to renew the lost tissue [93]. This was done in a
clonal screen for chromosome arm 2L, the same chromosome arm
we screened in the deficiency screen in our model. However, the
genes identified in the sec5ts screen [93] do not map to the
deficiencies that we have identified in our analysis (Table 1).
Because it is unknown if sec5ts–induced compensatory proliferation
requires caspase activity in apoptotic cells [93], it is not clear if this
is a model of apoptosis-induced proliferation.
In summary, we have developed and tested the feasibility of the
ey.hid-p35 model for genetic screening. We are confident that this
model will close gaps in our understanding of AiP regulation under
p35-expressing conditions and in p35-independent regeneration.
Finally, it will have implications for the understanding of
tumorigenesis by ‘undead’ as well as ‘genuine’ apoptotic tumor
cells [94].
Materials and Methods
Fly stocks and genetics
The following mutants and transgenic stocks were used: droncI29;
arkG8; spi1; spi01068; Egfrf2; rasDC40b, rl10a, ey-Gal4; ptc-Gal4; DE-Gal4;
tub-Gal80ts; UAS-p35; UAS-hid; UAS-GFP; wg-lacZ; puc-lacZ; kek1-
lacZ; spi-lacZ= spi01068; TRE-dsRed; GMR-hid; GMR-Gal4 UAS-egr.
UAS-based RNAi stocks of the following genes were obtained
from various stock centers (VDRC, Bloomington and NIG) and
were tested for suppression of AiP: dronc, dcp-1, drICE; bsk, egr, wgn,
PVR, dTraf1, dTraf2, Rho1, msn, slpr, Tak1, dMekk1, dAsk1, hep,
dMkk4, Jra, kay, spi, Egfr. The exact genotype of ey.hid-p35 is UAS-
hid; ey-Gal4 UAS-p35/CyO,tub-Gal80. Expression of tub-Gal80 in this
stock suppresses the semi-lethality associated with ey-induced
expression of hid and p35.
Mosaic analysis
Larvae of the following genotype were heat shocked for 15min
at 37uC, raised at room temperature for 48 h before they were
analyzed at the late 3rd instar larval stage. Genotype: hs-FLP/UAS-
hid; UAS-p35/act.y+.Gal4 UAS-GFP; puc-lacZ/+.
Tissue ablation using ptcts.hid and DEts.hid
Larvae of genotype UAS-hid/+; ptc-Gal4 tub-Gal80ts/+; UAS-
GFP/+ (Figure 3) and UAS-hid/+; UAS-GFP/+; DE-Gal4 tub-
Gal80ts/+ (Figure 6) were raised at 18uC. hid expression was
induced by temporal temperature shift to 30uC for the indicated
amount of time (Figure 3) or for 12 hours (Figure 6E). After the
indicated recovery periods at 18uC, discs were dissected and
analyzed as indicated in the panels.
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PH3 labelling and statistics in DEts.hid model
Two rounds of experiments (ts12hR24h, at least 20 discs were
analyzed each round) were done for both DEts.GFP (control) and
DEts.hid. Increase of PH3-positive cells in dorsal eye disc portions
of DEts.hid animals are consistently observed. PH3-positive cell
numbers were counted in dorsal (GFP+) and ventral eye disc
portions in selected discs. Size of the dorsal (GFP+) and ventral eye
disc portions were measured through the ‘‘histogram’’ function in
Adobe Photoshop CS. To compare the density of PH3+ cells in
each disc portion, number of PH3+ cells were divided by size (in
pixels) of the corresponding tissue which is used to calculate the
number of cells in 100,000 pixels (density). Such normalized
density of PH3+ cells in various portions of eye discs (mean 6 SD)
were used for the statistical chart. PH3+ cell numbers in
100,000 pixels is on average 88 in DEts.hid dorsal eye discs
compared to 62 in the control dorsal discs. Their statistical
significance was evaluated through a two-tailed, unpaired
Student’s t-Tests (P,0.04). In contrast, the number of PH3+ cells
are comparable in ventral disc portions of each genotype
suggesting that increased proliferation mostly occurred in the
dorsal part of the disc (at least at the time point of R24 h).
Immunohistochemistry
Imaginal discs were dissected from late 3rd instar larvae and
stained using standard protocols. Antibodies to the following
primary antigens were used: PH3 (Upstate), anti-cleaved Caspase-
3 (Cell Signaling), b-GAL (Promega), ELAV and Wg (DHSB).
Secondary antibodies were donkey Fab fragments from Jackson
ImmunoResearch. Images were taken with either a Zeiss
AxioImager or a confocal microscope.
Supporting Information
Figure S1 The JNK activity marker TRE-dsRed is induced in
‘undead’ ey.hid-p35 cells. Shown are (A) wild-type (wt), (B) ey.p35
and (C) ey.hid-p35 eye imaginal discs labeled for dsRed (JNK
marker, red in A–C; grey in A9–C9) and ELAV (photoreceptor
neurons, green in A–C; grey in A0–C0). Only ey.hid-p35 discs
induce TRE-dsRed expression (C, C9; arrow) and disrupt the ELAV
pattern (C0).
(TIF)
Figure S2 The UAS-dcp-1RNAi and UAS-drICERNAi stocks are
functional. Combined expression of UAS-dcp-1RNAi and UAS-
drICERNAi stocks suppresses both TUNEL-positive apoptosis (A,B)
and eye-ablation of GMR-hid (C,D) suggesting that these stocks
contain functional RNAi transgenes targeting dcp-1 and drICE.
(TIF)
Figure S3 Several UAS-RNAi transgenes of the JNK pathway
suppress GMR-egr. (A) The unmodified GMR-Gal4 UAS-eiger
(GMR.egr) eye ablation phenotype. (B–H) RNAi transgenes
targeting the genes indicated above the panels suppress the eye
ablation phenotype induced by GMR-Gal4 UAS-eiger (GMR.egr)
suggesting that they are functional.
(TIF)
Figure S4 Inactivation of JNK pathway genes in ey.hid-p35 eye
discs does not affect caspase activity. (A) A ey.hid-p35 disc labeled
for Cas3* and ELAV. (B) dronc RNAi suppresses Cas3* and
normalizes the ELAV pattern in ey.hid-p35 discs. (C–H) RNAi
transgenes targeting the indicated JNK pathway components
normalize the ELAV pattern, but fail to suppress Cas3* activity in
ey.hid-p35 discs suggesting that they suppress AiP downstream of
caspase activation.
(TIF)
Figure S5 Rho1 acts upstream of JNK in the ‘undead’ AiP
model. (A,A9,C,C9) ey.hid-p35 discs are characterized by strong
puc-lacZ (A,A9) and wg (C,C9) expression as well as disrupted
photoreceptor pattern (ELAV). (B,B9,D,D9) RNAi targeting Rho1
suppresses puc-lacZ (B,B9) and wg (D,D9) expression as well as
normalizes the ELAV pattern in ey.hid-p35 discs. Caspase activity
is not affected suggesting that Rho1 acts downstream of Dronc and
upstream of JNK.
(TIF)
Figure S6 Egfr is required for AiP in a wing model. (A) A control
wing disc expressing UAS-p35 under nubbin (nub)-Gal4 (nub.p35)
control shows normal Wg expression (A9) and little to no Cas3*
labeling (A0). (B) An experimental AiP disc expressing hid and p35
under nub control (nub.hid-p35) displays strong overgrowth with
abnormal Wg pattern (B9) and strong Cas3* labeling (B0).
Together with (D), these data suggests that nub.hid-p35 is a
suitable ‘undead’ AiP model. (C) A nub-Gal4 UAS-p35 (nub.p35)
control disc. puc-lacZ expression is detectable at low level. (D)
Coexpression of hid and p35 induces strong JNK activity (puc-lacZ)
in the enlarged nub domain. (E) RNAi targeting Egfr suppresses the
overrepresentation of the nub domain, but leaves puc-lacZ intact.
This result suggests that EGFR signaling is required for AiP in the
wing disc and acts downstream of JNK. (F,G) Control disc
expressing Egfr RNAi in the nub domain without hid, in the
presence (F) or absence (G) of p35. The size of the nub domain is
not significantly altered by Egfr RNAi compared to (C).
(TIF)
Figure S7 Induction of the JNK activity marker TRE-dsRed in
DEts.hid eye imaginal discs. (A–D) hid and GFP expression were
temporally induced for 12 h by temperature shift to 30uC during
early third instar larval stage as indicated in Figure 6E. dsRed
expression (red in A–D; grey in A9–D9; see arrows) was monitored
at 0 h (A), 6 h (B), 12 h (C) and 24 h (D) recovery after the
temperature shift. GFP (green in A–D; grey in A0–D0) marks the
DE domain. Blue is DAPI labeling to outline the discs. dsRed
labeling is weakly detectable at R0 h, peaks at 6 h after recovery
and fades off at R12 h. At R24 h, it is barely visible. (E) A DEts.
GFP control disc at 6 h recovery after the temperature shift,
labeled for dsRed (red in E, grey in E9). JNK activity is not
induced. GFP expression in (E0) is strong. Blue in (E) is DAPI
labeling to outline the discs.
(TIF)
Table S1 Chromosomal deficiencies tested in the AiP screen on
2L. Listed are the names of the deficiencies, the extent of the
chromosomal deletions and the score in the AiP screen. Green
marks suppressors and yellow marks enhancers. Deficiencies
marked with * could not be scored, because they caused lethality
in the ey.hid-p35 background.
(PDF)
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